 Joaquin Espinosa
Concepts (404)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 26 | 2025 | 492 | 7.370 |
Why?
| | Tumor Suppressor Protein p53 | 17 | 2025 | 531 | 4.640 |
Why?
| | Transcription, Genetic | 13 | 2021 | 1458 | 2.130 |
Why?
| | Cyclin-Dependent Kinases | 7 | 2022 | 132 | 1.950 |
Why?
| | Neoplasms | 11 | 2025 | 2666 | 1.750 |
Why?
| | Transcriptional Activation | 7 | 2023 | 379 | 1.740 |
Why?
| | Transcriptome | 5 | 2024 | 974 | 1.670 |
Why?
| | Janus Kinase Inhibitors | 2 | 2024 | 26 | 1.610 |
Why?
| | Chromosomes, Human, Pair 21 | 2 | 2024 | 44 | 1.510 |
Why?
| | Piperidines | 2 | 2024 | 208 | 1.430 |
Why?
| | Pyrimidines | 3 | 2024 | 472 | 1.350 |
Why?
| | Proteome | 4 | 2024 | 474 | 1.320 |
Why?
| | Interferons | 4 | 2023 | 199 | 1.200 |
Why?
| | Hypoxia | 2 | 2024 | 1108 | 0.960 |
Why?
| | Genomics | 2 | 2021 | 793 | 0.960 |
Why?
| | Gene Regulatory Networks | 2 | 2021 | 308 | 0.920 |
Why?
| | Antineoplastic Agents | 5 | 2025 | 2145 | 0.920 |
Why?
| | Erythropoiesis | 1 | 2024 | 54 | 0.890 |
Why?
| | Immunoglobulins | 1 | 2025 | 171 | 0.890 |
Why?
| | Heme | 1 | 2024 | 79 | 0.860 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 142 | 0.850 |
Why?
| | Receptors, Interferon | 2 | 2023 | 51 | 0.840 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.810 |
Why?
| | Gene Expression Regulation, Neoplastic | 8 | 2021 | 1402 | 0.800 |
Why?
| | Interferon-alpha | 3 | 2020 | 198 | 0.770 |
Why?
| | Transcription Factors | 9 | 2023 | 1717 | 0.750 |
Why?
| | Molecular Targeted Therapy | 1 | 2025 | 414 | 0.750 |
Why?
| | Blood | 1 | 2022 | 106 | 0.730 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 21 | 0.730 |
Why?
| | Cell Death | 1 | 2022 | 370 | 0.710 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 86 | 0.690 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 6 | 2025 | 66 | 0.680 |
Why?
| | Oncogenes | 1 | 2021 | 117 | 0.680 |
Why?
| | Databases, Genetic | 1 | 2021 | 237 | 0.660 |
Why?
| | Kynurenine | 2 | 2023 | 114 | 0.650 |
Why?
| | Humans | 67 | 2025 | 137514 | 0.650 |
Why?
| | Trisomy | 2 | 2019 | 83 | 0.640 |
Why?
| | Apoptosis | 10 | 2023 | 2557 | 0.630 |
Why?
| | Heart Defects, Congenital | 2 | 2025 | 832 | 0.620 |
Why?
| | Signal Transduction | 9 | 2024 | 5096 | 0.610 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 328 | 0.600 |
Why?
| | Cyclin-Dependent Kinase 8 | 6 | 2022 | 43 | 0.600 |
Why?
| | Enhancer Elements, Genetic | 1 | 2020 | 190 | 0.590 |
Why?
| | Metabolome | 1 | 2021 | 350 | 0.570 |
Why?
| | Autoimmunity | 2 | 2023 | 907 | 0.560 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 425 | 0.540 |
Why?
| | Case-Control Studies | 7 | 2025 | 3546 | 0.540 |
Why?
| | CD57 Antigens | 1 | 2016 | 18 | 0.500 |
Why?
| | Abatacept | 1 | 2016 | 53 | 0.500 |
Why?
| | Animals | 25 | 2025 | 37011 | 0.480 |
Why?
| | Cell Proliferation | 6 | 2023 | 2482 | 0.440 |
Why?
| | Cell Line, Tumor | 9 | 2023 | 3420 | 0.440 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2024 | 277 | 0.420 |
Why?
| | Proteomics | 4 | 2025 | 1113 | 0.410 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 683 | 0.400 |
Why?
| | Cyclins | 3 | 2022 | 91 | 0.390 |
Why?
| | Gene Expression Profiling | 5 | 2024 | 1770 | 0.390 |
Why?
| | Adult | 13 | 2025 | 37821 | 0.380 |
Why?
| | Mice | 14 | 2024 | 17843 | 0.380 |
Why?
| | Graft Rejection | 1 | 2016 | 623 | 0.370 |
Why?
| | Datasets as Topic | 2 | 2022 | 120 | 0.360 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2023 | 1092 | 0.350 |
Why?
| | Immunosuppressive Agents | 1 | 2016 | 891 | 0.340 |
Why?
| | Cell Differentiation | 3 | 2024 | 1979 | 0.340 |
Why?
| | RNA Polymerase II | 4 | 2019 | 324 | 0.340 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 614 | 0.340 |
Why?
| | Triple Negative Breast Neoplasms | 3 | 2019 | 202 | 0.340 |
Why?
| | Female | 23 | 2025 | 73162 | 0.320 |
Why?
| | Cell Line | 5 | 2021 | 2852 | 0.320 |
Why?
| | Kidney Transplantation | 1 | 2016 | 701 | 0.310 |
Why?
| | Mediator Complex | 3 | 2022 | 61 | 0.300 |
Why?
| | Biomarkers | 4 | 2025 | 4172 | 0.280 |
Why?
| | DNA-Binding Proteins | 4 | 2016 | 1507 | 0.270 |
Why?
| | Young Adult | 6 | 2025 | 13243 | 0.270 |
Why?
| | Male | 15 | 2025 | 67718 | 0.270 |
Why?
| | Proto-Oncogene Proteins | 2 | 2023 | 646 | 0.270 |
Why?
| | Promoter Regions, Genetic | 4 | 2013 | 1255 | 0.270 |
Why?
| | Gene Expression Regulation | 3 | 2012 | 2615 | 0.260 |
Why?
| | Adolescent | 7 | 2025 | 21555 | 0.260 |
Why?
| | Trypanosoma cruzi | 4 | 2000 | 39 | 0.260 |
Why?
| | Flow Cytometry | 3 | 2019 | 1185 | 0.260 |
Why?
| | Cytokines | 5 | 2024 | 2095 | 0.260 |
Why?
| | Interferon-gamma | 2 | 2019 | 790 | 0.250 |
Why?
| | Positive Transcriptional Elongation Factor B | 1 | 2006 | 29 | 0.250 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2009 | 121 | 0.240 |
Why?
| | Cell Cycle | 2 | 2008 | 604 | 0.240 |
Why?
| | Phosphorylation | 4 | 2022 | 1762 | 0.240 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2494 | 0.240 |
Why?
| | Metabolomics | 2 | 2021 | 679 | 0.230 |
Why?
| | Protein Binding | 5 | 2021 | 2229 | 0.220 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 13 | 0.220 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 504 | 0.210 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 193 | 0.210 |
Why?
| | Erythropoietin | 1 | 2024 | 95 | 0.210 |
Why?
| | Liposarcoma | 1 | 2023 | 26 | 0.210 |
Why?
| | Glutamine | 1 | 2023 | 104 | 0.210 |
Why?
| | Cyclin C | 1 | 2022 | 2 | 0.200 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 29 | 0.200 |
Why?
| | Alzheimer Disease | 2 | 2020 | 559 | 0.200 |
Why?
| | Diabetic Neuropathies | 1 | 2023 | 94 | 0.200 |
Why?
| | Growth Disorders | 1 | 2022 | 86 | 0.190 |
Why?
| | Centrosome | 2 | 2022 | 71 | 0.190 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2022 | 68 | 0.190 |
Why?
| | Nuclear Proteins | 4 | 2023 | 710 | 0.190 |
Why?
| | Child, Preschool | 4 | 2025 | 11097 | 0.190 |
Why?
| | Gene Silencing | 1 | 2023 | 195 | 0.190 |
Why?
| | Nervous System Diseases | 1 | 2025 | 265 | 0.190 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 155 | 0.190 |
Why?
| | Medulloblastoma | 1 | 2023 | 196 | 0.180 |
Why?
| | Acetyltransferases | 1 | 2001 | 22 | 0.180 |
Why?
| | Up-Regulation | 3 | 2021 | 846 | 0.180 |
Why?
| | Access to Information | 1 | 2021 | 49 | 0.180 |
Why?
| | Hematopoiesis | 2 | 2021 | 190 | 0.180 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 24 | 0.170 |
Why?
| | Stress, Physiological | 1 | 2024 | 445 | 0.170 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.170 |
Why?
| | Cilia | 2 | 2022 | 186 | 0.170 |
Why?
| | Doxorubicin | 3 | 2007 | 368 | 0.170 |
Why?
| | Middle Aged | 8 | 2025 | 33355 | 0.170 |
Why?
| | Azetidines | 1 | 2020 | 43 | 0.170 |
Why?
| | RNA, Messenger | 4 | 2021 | 2838 | 0.170 |
Why?
| | Models, Biological | 1 | 2008 | 1775 | 0.170 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 316 | 0.170 |
Why?
| | Data Mining | 1 | 2021 | 116 | 0.170 |
Why?
| | MicroRNAs | 2 | 2018 | 704 | 0.170 |
Why?
| | Quinolinic Acid | 1 | 2019 | 8 | 0.160 |
Why?
| | Eosinophilic Esophagitis | 1 | 2024 | 325 | 0.160 |
Why?
| | Anemia, Sickle Cell | 1 | 2023 | 266 | 0.160 |
Why?
| | Connective Tissue Diseases | 1 | 2020 | 84 | 0.160 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 24 | 0.160 |
Why?
| | DNA, Protozoan | 1 | 1999 | 31 | 0.160 |
Why?
| | Heart Diseases | 1 | 2023 | 359 | 0.160 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 386 | 0.160 |
Why?
| | Child | 6 | 2025 | 22037 | 0.160 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 56 | 0.160 |
Why?
| | Transcription Factor AP-1 | 1 | 1999 | 92 | 0.160 |
Why?
| | Protozoan Proteins | 1 | 1999 | 82 | 0.150 |
Why?
| | Occult Blood | 1 | 2018 | 34 | 0.150 |
Why?
| | Protein Domains | 2 | 2017 | 290 | 0.150 |
Why?
| | Coinfection | 1 | 2020 | 137 | 0.150 |
Why?
| | Calcinosis | 1 | 2020 | 235 | 0.150 |
Why?
| | Genome, Human | 1 | 2021 | 424 | 0.150 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 15 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 61 | 0.150 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 17 | 0.150 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 36 | 0.150 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 5792 | 0.150 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 87 | 0.150 |
Why?
| | Epithelial Cells | 1 | 2024 | 1099 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2018 | 54 | 0.140 |
Why?
| | Receptor, Notch1 | 1 | 2018 | 64 | 0.140 |
Why?
| | Bacterial Infections | 1 | 2020 | 251 | 0.140 |
Why?
| | Cellular Senescence | 1 | 2019 | 188 | 0.140 |
Why?
| | Cell Lineage | 1 | 2019 | 346 | 0.140 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 414 | 0.140 |
Why?
| | Inflammation | 2 | 2020 | 2837 | 0.140 |
Why?
| | Cell Survival | 1 | 2021 | 1122 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 502 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 256 | 0.140 |
Why?
| | Binding Sites | 3 | 2014 | 1310 | 0.140 |
Why?
| | Prospective Studies | 3 | 2025 | 7598 | 0.140 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 188 | 0.140 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2023 | 917 | 0.130 |
Why?
| | Hedgehog Proteins | 1 | 2018 | 197 | 0.130 |
Why?
| | Reminder Systems | 1 | 2018 | 176 | 0.130 |
Why?
| | Sulfonamides | 1 | 2020 | 513 | 0.130 |
Why?
| | Febrile Neutropenia | 1 | 2016 | 6 | 0.130 |
Why?
| | Protein Kinase Inhibitors | 2 | 2020 | 920 | 0.130 |
Why?
| | Histidine Kinase | 1 | 2016 | 34 | 0.130 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 392 | 0.130 |
Why?
| | Osteosarcoma | 1 | 2017 | 75 | 0.130 |
Why?
| | Antigens | 1 | 2018 | 358 | 0.130 |
Why?
| | T-Lymphocytes | 2 | 2022 | 1999 | 0.130 |
Why?
| | Exosomes | 1 | 2017 | 103 | 0.130 |
Why?
| | Proteolysis | 1 | 2017 | 180 | 0.120 |
Why?
| | Chromatin | 4 | 2016 | 524 | 0.120 |
Why?
| | HCT116 Cells | 3 | 2019 | 80 | 0.120 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 167 | 0.120 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 258 | 0.120 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 82 | 0.120 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1150 | 0.120 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1060 | 0.120 |
Why?
| | Kidney Function Tests | 1 | 2016 | 158 | 0.120 |
Why?
| | Autophagy | 1 | 2018 | 282 | 0.120 |
Why?
| | Drug Resistance | 1 | 2016 | 170 | 0.120 |
Why?
| | Allografts | 1 | 2016 | 148 | 0.120 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 398 | 0.120 |
Why?
| | Patient Participation | 1 | 2018 | 423 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 599 | 0.110 |
Why?
| | Disease Models, Animal | 2 | 2023 | 4295 | 0.110 |
Why?
| | Azepines | 1 | 2015 | 90 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 250 | 0.110 |
Why?
| | Phenotype | 1 | 2023 | 3205 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 398 | 0.110 |
Why?
| | Gene Expression | 1 | 2019 | 1505 | 0.110 |
Why?
| | Fibroblasts | 1 | 2019 | 990 | 0.110 |
Why?
| | Repressor Proteins | 1 | 2017 | 425 | 0.110 |
Why?
| | Early Detection of Cancer | 1 | 2018 | 420 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2018 | 770 | 0.110 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2013 | 12 | 0.110 |
Why?
| | Acetylation | 2 | 2007 | 254 | 0.110 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2016 | 765 | 0.110 |
Why?
| | Prognosis | 3 | 2019 | 4031 | 0.110 |
Why?
| | Mitogens | 1 | 2013 | 61 | 0.110 |
Why?
| | Immunologic Memory | 1 | 2016 | 369 | 0.100 |
Why?
| | Down-Regulation | 1 | 2015 | 658 | 0.100 |
Why?
| | Disease Progression | 1 | 2021 | 2755 | 0.100 |
Why?
| | Graft Survival | 1 | 2016 | 540 | 0.100 |
Why?
| | Follow-Up Studies | 3 | 2019 | 5139 | 0.100 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 170 | 0.100 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1061 | 0.100 |
Why?
| | Feedback, Physiological | 1 | 2012 | 78 | 0.100 |
Why?
| | Spain | 2 | 2025 | 41 | 0.100 |
Why?
| | Tumor Cells, Cultured | 3 | 2019 | 957 | 0.090 |
Why?
| | Glomerular Filtration Rate | 1 | 2016 | 746 | 0.090 |
Why?
| | RNA Stability | 1 | 2012 | 117 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1903 | 0.090 |
Why?
| | Immunohistochemistry | 1 | 2016 | 1740 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2006 | 869 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2018 | 799 | 0.090 |
Why?
| | Mass Screening | 1 | 2018 | 1264 | 0.080 |
Why?
| | Risk Factors | 3 | 2025 | 10356 | 0.080 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 565 | 0.080 |
Why?
| | Sirtuins | 1 | 2010 | 42 | 0.080 |
Why?
| | HeLa Cells | 3 | 2013 | 640 | 0.080 |
Why?
| | S Phase | 1 | 2009 | 78 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 455 | 0.080 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.080 |
Why?
| | Histones | 2 | 2007 | 641 | 0.080 |
Why?
| | Enzyme Activation | 2 | 2008 | 816 | 0.080 |
Why?
| | Receptors, Thyroid Hormone | 1 | 2008 | 21 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2023 | 2521 | 0.080 |
Why?
| | Hydroxyurea | 2 | 2023 | 34 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2838 | 0.070 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2007 | 45 | 0.070 |
Why?
| | Multiprotein Complexes | 1 | 2008 | 163 | 0.070 |
Why?
| | RNA | 1 | 2014 | 924 | 0.070 |
Why?
| | Formaldehyde | 1 | 2007 | 62 | 0.070 |
Why?
| | Radiation, Ionizing | 1 | 2007 | 81 | 0.070 |
Why?
| | Protein Kinases | 1 | 2009 | 319 | 0.070 |
Why?
| | Glycolysis | 2 | 2024 | 319 | 0.070 |
Why?
| | Genome-Wide Association Study | 2 | 2025 | 1436 | 0.070 |
Why?
| | RNA Precursors | 1 | 2007 | 153 | 0.060 |
Why?
| | Fluorouracil | 1 | 2007 | 213 | 0.060 |
Why?
| | Transcription Factors, TFII | 1 | 2006 | 41 | 0.060 |
Why?
| | DNA | 2 | 2006 | 1460 | 0.060 |
Why?
| | High Mobility Group Proteins | 1 | 2006 | 44 | 0.060 |
Why?
| | Kinetics | 2 | 2007 | 1679 | 0.060 |
Why?
| | Transcription Factor TFIIH | 1 | 2006 | 37 | 0.060 |
Why?
| | Transcriptional Elongation Factors | 1 | 2006 | 40 | 0.060 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2006 | 139 | 0.060 |
Why?
| | Protein Transport | 1 | 2007 | 443 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2249 | 0.060 |
Why?
| | Serine | 1 | 2006 | 141 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2019 | 3020 | 0.060 |
Why?
| | Glucose | 1 | 2010 | 1018 | 0.060 |
Why?
| | Protein Isoforms | 1 | 2006 | 403 | 0.060 |
Why?
| | Hemoglobin, Sickle | 1 | 2023 | 18 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2019 | 868 | 0.050 |
Why?
| | Headache | 1 | 2025 | 154 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 974 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 59 | 0.050 |
Why?
| | Intermediate Filaments | 1 | 2023 | 28 | 0.050 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 20 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 45 | 0.050 |
Why?
| | L-Selectin | 1 | 2023 | 26 | 0.050 |
Why?
| | Perforin | 1 | 2023 | 19 | 0.050 |
Why?
| | Proline | 1 | 2023 | 80 | 0.050 |
Why?
| | Neurofilament Proteins | 1 | 2023 | 52 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 224 | 0.050 |
Why?
| | Patient Acuity | 1 | 2023 | 47 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 156 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 171 | 0.050 |
Why?
| | Esophagus | 1 | 2024 | 255 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 200 | 0.050 |
Why?
| | Hemolysis | 1 | 2023 | 205 | 0.050 |
Why?
| | Centrioles | 1 | 2022 | 44 | 0.050 |
Why?
| | DNA Footprinting | 1 | 2001 | 33 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2022 | 156 | 0.050 |
Why?
| | Neuroimaging | 1 | 2024 | 291 | 0.050 |
Why?
| | p300-CBP Transcription Factors | 1 | 2001 | 28 | 0.040 |
Why?
| | Genes, Protozoan | 1 | 2000 | 13 | 0.040 |
Why?
| | Nitric Oxide | 2 | 1997 | 914 | 0.040 |
Why?
| | Immunoblotting | 1 | 2001 | 307 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 45 | 0.040 |
Why?
| | RNA Helicases | 1 | 2000 | 30 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2001 | 61 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2025 | 1066 | 0.040 |
Why?
| | Oligonucleotide Probes | 1 | 1999 | 51 | 0.040 |
Why?
| | Electrophoresis | 1 | 1999 | 33 | 0.040 |
Why?
| | Heterozygote | 1 | 2020 | 292 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 186 | 0.040 |
Why?
| | Interferon Type I | 1 | 2020 | 142 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2018 | 4206 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 16 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2020 | 172 | 0.040 |
Why?
| | Genetic Testing | 1 | 2022 | 453 | 0.040 |
Why?
| | Purines | 1 | 2020 | 176 | 0.040 |
Why?
| | Microtubules | 1 | 2022 | 270 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 1999 | 55 | 0.040 |
Why?
| | Antigens, Neoplasm | 1 | 2022 | 322 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 75 | 0.040 |
Why?
| | Drosophila melanogaster | 1 | 2001 | 228 | 0.040 |
Why?
| | Heart | 1 | 2023 | 660 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 13 | 0.040 |
Why?
| | Immunotherapy | 1 | 2024 | 647 | 0.040 |
Why?
| | Immunotherapy, Adoptive | 1 | 2022 | 324 | 0.040 |
Why?
| | Postal Service | 1 | 2018 | 34 | 0.040 |
Why?
| | Myelopoiesis | 1 | 2018 | 8 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 1999 | 190 | 0.040 |
Why?
| | Lymphopoiesis | 1 | 2018 | 26 | 0.040 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 665 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 88 | 0.040 |
Why?
| | DNA, Single-Stranded | 1 | 1999 | 118 | 0.040 |
Why?
| | Arginine | 2 | 1997 | 274 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 367 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2018 | 127 | 0.040 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 55 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2020 | 222 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2857 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2193 | 0.030 |
Why?
| | Antibodies | 1 | 1999 | 414 | 0.030 |
Why?
| | omega-N-Methylarginine | 1 | 1997 | 27 | 0.030 |
Why?
| | Pyrazoles | 1 | 2020 | 427 | 0.030 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 13 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 601 | 0.030 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 30 | 0.030 |
Why?
| | Blotting, Western | 1 | 1999 | 1227 | 0.030 |
Why?
| | Aged | 3 | 2025 | 23798 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2025 | 2420 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 367 | 0.030 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 70 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2019 | 659 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 193 | 0.030 |
Why?
| | Imidazoles | 1 | 2017 | 244 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1271 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 14 | 0.030 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 435 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 413 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 56 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2197 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 141 | 0.030 |
Why?
| | Piperazines | 1 | 2017 | 351 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 832 | 0.030 |
Why?
| | Complement System Proteins | 1 | 2017 | 328 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1980 | 0.030 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 21 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 972 | 0.030 |
Why?
| | Genes, ras | 1 | 2013 | 96 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2013 | 144 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 930 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2018 | 847 | 0.020 |
Why?
| | Interleukin-1 | 1 | 2017 | 963 | 0.020 |
Why?
| | Oxidative Stress | 1 | 1999 | 1307 | 0.020 |
Why?
| | Liver | 1 | 2020 | 1940 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1279 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1790 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 734 | 0.020 |
Why?
| | Cell Respiration | 1 | 2010 | 102 | 0.020 |
Why?
| | Glucose Transporter Type 1 | 1 | 2010 | 50 | 0.020 |
Why?
| | Daunorubicin | 1 | 2009 | 26 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2009 | 29 | 0.020 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2009 | 16 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2009 | 30 | 0.020 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 67 | 0.020 |
Why?
| | Coenzymes | 1 | 2008 | 20 | 0.020 |
Why?
| | Caffeine | 1 | 2009 | 68 | 0.020 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 13 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2008 | 385 | 0.020 |
Why?
| | RNA Caps | 1 | 2007 | 35 | 0.020 |
Why?
| | Genes, myc | 1 | 2007 | 48 | 0.020 |
Why?
| | Poly A | 1 | 2007 | 50 | 0.020 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2007 | 24 | 0.020 |
Why?
| | DNA Replication | 1 | 2009 | 242 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2007 | 285 | 0.020 |
Why?
| | Dizocilpine Maleate | 2 | 1997 | 22 | 0.020 |
Why?
| | Cyclic GMP | 2 | 1997 | 94 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 15628 | 0.020 |
Why?
| | Nitric Oxide Synthase | 2 | 1997 | 241 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1357 | 0.010 |
Why?
| | Mass Spectrometry | 1 | 2008 | 741 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2016 | 7593 | 0.010 |
Why?
| | Infant | 1 | 2017 | 9467 | 0.010 |
Why?
| | Myocytes, Cardiac | 1 | 2007 | 528 | 0.010 |
Why?
| | Mutation | 1 | 2013 | 3964 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1586 | 0.010 |
Why?
| | Genomic Library | 1 | 2000 | 17 | 0.010 |
Why?
| | RNA, Protozoan | 1 | 2000 | 59 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 269 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 2000 | 225 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2000 | 523 | 0.010 |
Why?
| | Bucladesine | 1 | 1997 | 26 | 0.010 |
Why?
| | Guanosine Monophosphate | 1 | 1997 | 8 | 0.010 |
Why?
| | Guanosine Diphosphate | 1 | 1997 | 21 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2000 | 2146 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2000 | 2901 | 0.010 |
Why?
| | Amino Acid Oxidoreductases | 1 | 1995 | 20 | 0.010 |
Why?
| | Guanylate Cyclase | 1 | 1995 | 37 | 0.010 |
Why?
| | Citrulline | 1 | 1995 | 45 | 0.010 |
Why?
| | Glutamic Acid | 1 | 1997 | 249 | 0.010 |
Why?
| | Movement | 1 | 1997 | 273 | 0.010 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 1995 | 222 | 0.010 |
Why?
| | Amino Acids | 1 | 1997 | 503 | 0.010 |
Why?
|
|
Espinosa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|